Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

Recruiting now

Conditions studied: Hyperkyphosis, Hyperlordosis, Congenital Scoliosis, Neuromuscular Scoliosis, Idiopathic Scoliosis

In brief

Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)

Key facts

Study ID

NCT05281757

Run by

Aesculap AG

People needed

200

Starts

2022-02-18

Expected to finish

2028-10-01

Last updated by the study team

2026-06-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Informed consent in the documentation of clinical and radiological results of patients who are minimum 18 years old
• Informed consent in the documentation of clinical and radiological results of patients AND legal representative (parent) for patients who are younger than 18
• Patient's indication according to IFU
• Patient is not pregnant

You may not qualify if…

• Patient's clear unability or unwillingness to participate in follow-up examinations

Where it is running

• Hospital Universiti Kebangsaan Malaysia (HUKM) — Kuala Lumpur, Malaysia (enrolling)
• University Hospital Brno — Brno, Czechia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.